1 Market Overview

1.1 Product Overview and Scope of Respiratory Syncytial Virus Vaccines

1.2 Market Estimation Caveats and Base Year

1.3 Classification of Respiratory Syncytial Virus Vaccines by Type

1.3.1 Overview: Global Respiratory Syncytial Virus Vaccines Market Size by Type: 2018 Versus 2022 Versus 2029

1.3.2 Global Respiratory Syncytial Virus Vaccines Consumption Value Market Share by Type in 2022

1.3.3 Palivizumab

1.3.4 RSVpreF PF06928316

1.3.5 RSVPreF3 OA (GSK3844766A)

1.3.6 mRNA-1345

1.3.7 Janssen RSV Vaccine

1.3.8 ResVax

1.3.9 Nirsevimab (MEDI8897)

1.3.10 MVA-BN RSV

1.4 Global Respiratory Syncytial Virus Vaccines Market by Application

1.4.1 Overview: Global Respiratory Syncytial Virus Vaccines Market Size by Application: 2018 Versus 2022 Versus 2029

1.4.2 Hospital

1.4.3 Clinic

1.4.4 Research Institute

1.5 Global Respiratory Syncytial Virus Vaccines Market Size & Forecast

1.6 Global Respiratory Syncytial Virus Vaccines Market Size and Forecast by Region

1.6.1 Global Respiratory Syncytial Virus Vaccines Market Size by Region: 2018 VS 2022 VS 2029

1.6.2 Global Respiratory Syncytial Virus Vaccines Market Size by Region, (2018-2029)

1.6.3 North America Respiratory Syncytial Virus Vaccines Market Size and Prospect (2018-2029)

1.6.4 Europe Respiratory Syncytial Virus Vaccines Market Size and Prospect (2018-2029)

1.6.5 Asia-Pacific Respiratory Syncytial Virus Vaccines Market Size and Prospect (2018-2029)

1.6.6 South America Respiratory Syncytial Virus Vaccines Market Size and Prospect (2018-2029)

1.6.7 Middle East and Africa Respiratory Syncytial Virus Vaccines Market Size and Prospect (2018-2029)

2 Company Profiles

2.1 Pfizer Inc.Pfizer Inc.

2.1.1 Pfizer Inc.Pfizer Inc. Details

2.1.2 Pfizer Inc.Pfizer Inc. Major Business

2.1.3 Pfizer Inc.Pfizer Inc. Respiratory Syncytial Virus Vaccines Product and Solutions

2.1.4 Pfizer Inc.Pfizer Inc. Respiratory Syncytial Virus Vaccines Revenue, Gross Margin and Market Share (2018-2023)

2.1.5 Pfizer Inc.Pfizer Inc. Recent Developments and Future Plans

2.2 Sanofi

2.2.1 Sanofi Details

2.2.2 Sanofi Major Business

2.2.3 Sanofi Respiratory Syncytial Virus Vaccines Product and Solutions

2.2.4 Sanofi Respiratory Syncytial Virus Vaccines Revenue, Gross Margin and Market Share (2018-2023)

2.2.5 Sanofi Recent Developments and Future Plans

2.3 Merck Sharp & Dohme

2.3.1 Merck Sharp & Dohme Details

2.3.2 Merck Sharp & Dohme Major Business

2.3.3 Merck Sharp & Dohme Respiratory Syncytial Virus Vaccines Product and Solutions

2.3.4 Merck Sharp & Dohme Respiratory Syncytial Virus Vaccines Revenue, Gross Margin and Market Share (2018-2023)

2.3.5 Merck Sharp & Dohme Recent Developments and Future Plans

2.4 GlaxoSmithKline

2.4.1 GlaxoSmithKline Details

2.4.2 GlaxoSmithKline Major Business

2.4.3 GlaxoSmithKline Respiratory Syncytial Virus Vaccines Product and Solutions

2.4.4 GlaxoSmithKline Respiratory Syncytial Virus Vaccines Revenue, Gross Margin and Market Share (2018-2023)

2.4.5 GlaxoSmithKline Recent Developments and Future Plans

2.5 SOBI

2.5.1 SOBI Details

2.5.2 SOBI Major Business

2.5.3 SOBI Respiratory Syncytial Virus Vaccines Product and Solutions

2.5.4 SOBI Respiratory Syncytial Virus Vaccines Revenue, Gross Margin and Market Share (2018-2023)

2.5.5 SOBI Recent Developments and Future Plans

2.6 Johnson & Johnson

2.6.1 Johnson & Johnson Details

2.6.2 Johnson & Johnson Major Business

2.6.3 Johnson & Johnson Respiratory Syncytial Virus Vaccines Product and Solutions

2.6.4 Johnson & Johnson Respiratory Syncytial Virus Vaccines Revenue, Gross Margin and Market Share (2018-2023)

2.6.5 Johnson & Johnson Recent Developments and Future Plans

2.7 Bavarian Nordic

2.7.1 Bavarian Nordic Details

2.7.2 Bavarian Nordic Major Business

2.7.3 Bavarian Nordic Respiratory Syncytial Virus Vaccines Product and Solutions

2.7.4 Bavarian Nordic Respiratory Syncytial Virus Vaccines Revenue, Gross Margin and Market Share (2018-2023)

2.7.5 Bavarian Nordic Recent Developments and Future Plans

2.8 Novavax

2.8.1 Novavax Details

2.8.2 Novavax Major Business

2.8.3 Novavax Respiratory Syncytial Virus Vaccines Product and Solutions

2.8.4 Novavax Respiratory Syncytial Virus Vaccines Revenue, Gross Margin and Market Share (2018-2023)

2.8.5 Novavax Recent Developments and Future Plans

2.9 AstraZeneca

2.9.1 AstraZeneca Details

2.9.2 AstraZeneca Major Business

2.9.3 AstraZeneca Respiratory Syncytial Virus Vaccines Product and Solutions

2.9.4 AstraZeneca Respiratory Syncytial Virus Vaccines Revenue, Gross Margin and Market Share (2018-2023)

2.9.5 AstraZeneca Recent Developments and Future Plans

2.10 Moderna

2.10.1 Moderna Details

2.10.2 Moderna Major Business

2.10.3 Moderna Respiratory Syncytial Virus Vaccines Product and Solutions

2.10.4 Moderna Respiratory Syncytial Virus Vaccines Revenue, Gross Margin and Market Share (2018-2023)

2.10.5 Moderna Recent Developments and Future Plans

2.11 Codagenix

2.11.1 Codagenix Details

2.11.2 Codagenix Major Business

2.11.3 Codagenix Respiratory Syncytial Virus Vaccines Product and Solutions

2.11.4 Codagenix Respiratory Syncytial Virus Vaccines Revenue, Gross Margin and Market Share (2018-2023)

2.11.5 Codagenix Recent Developments and Future Plans

2.12 Intravacc

2.12.1 Intravacc Details

2.12.2 Intravacc Major Business

2.12.3 Intravacc Respiratory Syncytial Virus Vaccines Product and Solutions

2.12.4 Intravacc Respiratory Syncytial Virus Vaccines Revenue, Gross Margin and Market Share (2018-2023)

2.12.5 Intravacc Recent Developments and Future Plans

2.13 Alphavax

2.13.1 Alphavax Details

2.13.2 Alphavax Major Business

2.13.3 Alphavax Respiratory Syncytial Virus Vaccines Product and Solutions

2.13.4 Alphavax Respiratory Syncytial Virus Vaccines Revenue, Gross Margin and Market Share (2018-2023)

2.13.5 Alphavax Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Respiratory Syncytial Virus Vaccines Revenue and Share by Players (2018-2023)

3.2 Market Share Analysis (2022)

3.2.1 Market Share of Respiratory Syncytial Virus Vaccines by Company Revenue

3.2.2 Top 3 Respiratory Syncytial Virus Vaccines Players Market Share in 2022

3.2.3 Top 6 Respiratory Syncytial Virus Vaccines Players Market Share in 2022

3.3 Respiratory Syncytial Virus Vaccines Market: Overall Company Footprint Analysis

3.3.1 Respiratory Syncytial Virus Vaccines Market: Region Footprint

3.3.2 Respiratory Syncytial Virus Vaccines Market: Company Product Type Footprint

3.3.3 Respiratory Syncytial Virus Vaccines Market: Company Product Application Footprint

3.4 New Market Entrants and Barriers to Market Entry

3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

4.1 Global Respiratory Syncytial Virus Vaccines Consumption Value and Market Share by Type (2018-2023)

4.2 Global Respiratory Syncytial Virus Vaccines Market Forecast by Type (2024-2029)

5 Market Size Segment by Application

5.1 Global Respiratory Syncytial Virus Vaccines Consumption Value Market Share by Application (2018-2023)

5.2 Global Respiratory Syncytial Virus Vaccines Market Forecast by Application (2024-2029)

6 North America

6.1 North America Respiratory Syncytial Virus Vaccines Consumption Value by Type (2018-2029)

6.2 North America Respiratory Syncytial Virus Vaccines Consumption Value by Application (2018-2029)

6.3 North America Respiratory Syncytial Virus Vaccines Market Size by Country

6.3.1 North America Respiratory Syncytial Virus Vaccines Consumption Value by Country (2018-2029)

6.3.2 United States Respiratory Syncytial Virus Vaccines Market Size and Forecast (2018-2029)

6.3.3 Canada Respiratory Syncytial Virus Vaccines Market Size and Forecast (2018-2029)

6.3.4 Mexico Respiratory Syncytial Virus Vaccines Market Size and Forecast (2018-2029)

7 Europe

7.1 Europe Respiratory Syncytial Virus Vaccines Consumption Value by Type (2018-2029)

7.2 Europe Respiratory Syncytial Virus Vaccines Consumption Value by Application (2018-2029)

7.3 Europe Respiratory Syncytial Virus Vaccines Market Size by Country

7.3.1 Europe Respiratory Syncytial Virus Vaccines Consumption Value by Country (2018-2029)

7.3.2 Germany Respiratory Syncytial Virus Vaccines Market Size and Forecast (2018-2029)

7.3.3 France Respiratory Syncytial Virus Vaccines Market Size and Forecast (2018-2029)

7.3.4 United Kingdom Respiratory Syncytial Virus Vaccines Market Size and Forecast (2018-2029)

7.3.5 Russia Respiratory Syncytial Virus Vaccines Market Size and Forecast (2018-2029)

7.3.6 Italy Respiratory Syncytial Virus Vaccines Market Size and Forecast (2018-2029)

8 Asia-Pacific

8.1 Asia-Pacific Respiratory Syncytial Virus Vaccines Consumption Value by Type (2018-2029)

8.2 Asia-Pacific Respiratory Syncytial Virus Vaccines Consumption Value by Application (2018-2029)

8.3 Asia-Pacific Respiratory Syncytial Virus Vaccines Market Size by Region

8.3.1 Asia-Pacific Respiratory Syncytial Virus Vaccines Consumption Value by Region (2018-2029)

8.3.2 China Respiratory Syncytial Virus Vaccines Market Size and Forecast (2018-2029)

8.3.3 Japan Respiratory Syncytial Virus Vaccines Market Size and Forecast (2018-2029)

8.3.4 South Korea Respiratory Syncytial Virus Vaccines Market Size and Forecast (2018-2029)

8.3.5 India Respiratory Syncytial Virus Vaccines Market Size and Forecast (2018-2029)

8.3.6 Southeast Asia Respiratory Syncytial Virus Vaccines Market Size and Forecast (2018-2029)

8.3.7 Australia Respiratory Syncytial Virus Vaccines Market Size and Forecast (2018-2029)

9 South America

9.1 South America Respiratory Syncytial Virus Vaccines Consumption Value by Type (2018-2029)

9.2 South America Respiratory Syncytial Virus Vaccines Consumption Value by Application (2018-2029)

9.3 South America Respiratory Syncytial Virus Vaccines Market Size by Country

9.3.1 South America Respiratory Syncytial Virus Vaccines Consumption Value by Country (2018-2029)

9.3.2 Brazil Respiratory Syncytial Virus Vaccines Market Size and Forecast (2018-2029)

9.3.3 Argentina Respiratory Syncytial Virus Vaccines Market Size and Forecast (2018-2029)

10 Middle East & Africa

10.1 Middle East & Africa Respiratory Syncytial Virus Vaccines Consumption Value by Type (2018-2029)

10.2 Middle East & Africa Respiratory Syncytial Virus Vaccines Consumption Value by Application (2018-2029)

10.3 Middle East & Africa Respiratory Syncytial Virus Vaccines Market Size by Country

10.3.1 Middle East & Africa Respiratory Syncytial Virus Vaccines Consumption Value by Country (2018-2029)

10.3.2 Turkey Respiratory Syncytial Virus Vaccines Market Size and Forecast (2018-2029)

10.3.3 Saudi Arabia Respiratory Syncytial Virus Vaccines Market Size and Forecast (2018-2029)

10.3.4 UAE Respiratory Syncytial Virus Vaccines Market Size and Forecast (2018-2029)

11 Market Dynamics

11.1 Respiratory Syncytial Virus Vaccines Market Drivers

11.2 Respiratory Syncytial Virus Vaccines Market Restraints

11.3 Respiratory Syncytial Virus Vaccines Trends Analysis

11.4 Porters Five Forces Analysis

11.4.1 Threat of New Entrants

11.4.2 Bargaining Power of Suppliers

11.4.3 Bargaining Power of Buyers

11.4.4 Threat of Substitutes

11.4.5 Competitive Rivalry

11.5 Influence of COVID-19 and Russia-Ukraine War

11.5.1 Influence of COVID-19

11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis

12.1 Respiratory Syncytial Virus Vaccines Industry Chain

12.2 Respiratory Syncytial Virus Vaccines Upstream Analysis

12.3 Respiratory Syncytial Virus Vaccines Midstream Analysis

12.4 Respiratory Syncytial Virus Vaccines Downstream Analysis

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Research Process and Data Source

14.3 Disclaimer

List of Tables

Table 1. Global Respiratory Syncytial Virus Vaccines Consumption Value by Type, (USD Million), 2018 & 2022 & 2029

Table 2. Global Respiratory Syncytial Virus Vaccines Consumption Value by Application, (USD Million), 2018 & 2022 & 2029

Table 3. Global Respiratory Syncytial Virus Vaccines Consumption Value by Region (2018-2023) & (USD Million)

Table 4. Global Respiratory Syncytial Virus Vaccines Consumption Value by Region (2024-2029) & (USD Million)

Table 5. Pfizer Inc.Pfizer Inc. Company Information, Head Office, and Major Competitors

Table 6. Pfizer Inc.Pfizer Inc. Major Business

Table 7. Pfizer Inc.Pfizer Inc. Respiratory Syncytial Virus Vaccines Product and Solutions

Table 8. Pfizer Inc.Pfizer Inc. Respiratory Syncytial Virus Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 9. Pfizer Inc.Pfizer Inc. Recent Developments and Future Plans

Table 10. Sanofi Company Information, Head Office, and Major Competitors

Table 11. Sanofi Major Business

Table 12. Sanofi Respiratory Syncytial Virus Vaccines Product and Solutions

Table 13. Sanofi Respiratory Syncytial Virus Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 14. Sanofi Recent Developments and Future Plans

Table 15. Merck Sharp & Dohme Company Information, Head Office, and Major Competitors

Table 16. Merck Sharp & Dohme Major Business

Table 17. Merck Sharp & Dohme Respiratory Syncytial Virus Vaccines Product and Solutions

Table 18. Merck Sharp & Dohme Respiratory Syncytial Virus Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 19. Merck Sharp & Dohme Recent Developments and Future Plans

Table 20. GlaxoSmithKline Company Information, Head Office, and Major Competitors

Table 21. GlaxoSmithKline Major Business

Table 22. GlaxoSmithKline Respiratory Syncytial Virus Vaccines Product and Solutions

Table 23. GlaxoSmithKline Respiratory Syncytial Virus Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 24. GlaxoSmithKline Recent Developments and Future Plans

Table 25. SOBI Company Information, Head Office, and Major Competitors

Table 26. SOBI Major Business

Table 27. SOBI Respiratory Syncytial Virus Vaccines Product and Solutions

Table 28. SOBI Respiratory Syncytial Virus Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 29. SOBI Recent Developments and Future Plans

Table 30. Johnson & Johnson Company Information, Head Office, and Major Competitors

Table 31. Johnson & Johnson Major Business

Table 32. Johnson & Johnson Respiratory Syncytial Virus Vaccines Product and Solutions

Table 33. Johnson & Johnson Respiratory Syncytial Virus Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 34. Johnson & Johnson Recent Developments and Future Plans

Table 35. Bavarian Nordic Company Information, Head Office, and Major Competitors

Table 36. Bavarian Nordic Major Business

Table 37. Bavarian Nordic Respiratory Syncytial Virus Vaccines Product and Solutions

Table 38. Bavarian Nordic Respiratory Syncytial Virus Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 39. Bavarian Nordic Recent Developments and Future Plans

Table 40. Novavax Company Information, Head Office, and Major Competitors

Table 41. Novavax Major Business

Table 42. Novavax Respiratory Syncytial Virus Vaccines Product and Solutions

Table 43. Novavax Respiratory Syncytial Virus Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 44. Novavax Recent Developments and Future Plans

Table 45. AstraZeneca Company Information, Head Office, and Major Competitors

Table 46. AstraZeneca Major Business

Table 47. AstraZeneca Respiratory Syncytial Virus Vaccines Product and Solutions

Table 48. AstraZeneca Respiratory Syncytial Virus Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 49. AstraZeneca Recent Developments and Future Plans

Table 50. Moderna Company Information, Head Office, and Major Competitors

Table 51. Moderna Major Business

Table 52. Moderna Respiratory Syncytial Virus Vaccines Product and Solutions

Table 53. Moderna Respiratory Syncytial Virus Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 54. Moderna Recent Developments and Future Plans

Table 55. Codagenix Company Information, Head Office, and Major Competitors

Table 56. Codagenix Major Business

Table 57. Codagenix Respiratory Syncytial Virus Vaccines Product and Solutions

Table 58. Codagenix Respiratory Syncytial Virus Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 59. Codagenix Recent Developments and Future Plans

Table 60. Intravacc Company Information, Head Office, and Major Competitors

Table 61. Intravacc Major Business

Table 62. Intravacc Respiratory Syncytial Virus Vaccines Product and Solutions

Table 63. Intravacc Respiratory Syncytial Virus Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 64. Intravacc Recent Developments and Future Plans

Table 65. Alphavax Company Information, Head Office, and Major Competitors

Table 66. Alphavax Major Business

Table 67. Alphavax Respiratory Syncytial Virus Vaccines Product and Solutions

Table 68. Alphavax Respiratory Syncytial Virus Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 69. Alphavax Recent Developments and Future Plans

Table 70. Global Respiratory Syncytial Virus Vaccines Revenue (USD Million) by Players (2018-2023)

Table 71. Global Respiratory Syncytial Virus Vaccines Revenue Share by Players (2018-2023)

Table 72. Breakdown of Respiratory Syncytial Virus Vaccines by Company Type (Tier 1, Tier 2, and Tier 3)

Table 73. Market Position of Players in Respiratory Syncytial Virus Vaccines, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022

Table 74. Head Office of Key Respiratory Syncytial Virus Vaccines Players

Table 75. Respiratory Syncytial Virus Vaccines Market: Company Product Type Footprint

Table 76. Respiratory Syncytial Virus Vaccines Market: Company Product Application Footprint

Table 77. Respiratory Syncytial Virus Vaccines New Market Entrants and Barriers to Market Entry

Table 78. Respiratory Syncytial Virus Vaccines Mergers, Acquisition, Agreements, and Collaborations

Table 79. Global Respiratory Syncytial Virus Vaccines Consumption Value (USD Million) by Type (2018-2023)

Table 80. Global Respiratory Syncytial Virus Vaccines Consumption Value Share by Type (2018-2023)

Table 81. Global Respiratory Syncytial Virus Vaccines Consumption Value Forecast by Type (2024-2029)

Table 82. Global Respiratory Syncytial Virus Vaccines Consumption Value by Application (2018-2023)

Table 83. Global Respiratory Syncytial Virus Vaccines Consumption Value Forecast by Application (2024-2029)

Table 84. North America Respiratory Syncytial Virus Vaccines Consumption Value by Type (2018-2023) & (USD Million)

Table 85. North America Respiratory Syncytial Virus Vaccines Consumption Value by Type (2024-2029) & (USD Million)

Table 86. North America Respiratory Syncytial Virus Vaccines Consumption Value by Application (2018-2023) & (USD Million)

Table 87. North America Respiratory Syncytial Virus Vaccines Consumption Value by Application (2024-2029) & (USD Million)

Table 88. North America Respiratory Syncytial Virus Vaccines Consumption Value by Country (2018-2023) & (USD Million)

Table 89. North America Respiratory Syncytial Virus Vaccines Consumption Value by Country (2024-2029) & (USD Million)

Table 90. Europe Respiratory Syncytial Virus Vaccines Consumption Value by Type (2018-2023) & (USD Million)

Table 91. Europe Respiratory Syncytial Virus Vaccines Consumption Value by Type (2024-2029) & (USD Million)

Table 92. Europe Respiratory Syncytial Virus Vaccines Consumption Value by Application (2018-2023) & (USD Million)

Table 93. Europe Respiratory Syncytial Virus Vaccines Consumption Value by Application (2024-2029) & (USD Million)

Table 94. Europe Respiratory Syncytial Virus Vaccines Consumption Value by Country (2018-2023) & (USD Million)

Table 95. Europe Respiratory Syncytial Virus Vaccines Consumption Value by Country (2024-2029) & (USD Million)

Table 96. Asia-Pacific Respiratory Syncytial Virus Vaccines Consumption Value by Type (2018-2023) & (USD Million)

Table 97. Asia-Pacific Respiratory Syncytial Virus Vaccines Consumption Value by Type (2024-2029) & (USD Million)

Table 98. Asia-Pacific Respiratory Syncytial Virus Vaccines Consumption Value by Application (2018-2023) & (USD Million)

Table 99. Asia-Pacific Respiratory Syncytial Virus Vaccines Consumption Value by Application (2024-2029) & (USD Million)

Table 100. Asia-Pacific Respiratory Syncytial Virus Vaccines Consumption Value by Region (2018-2023) & (USD Million)

Table 101. Asia-Pacific Respiratory Syncytial Virus Vaccines Consumption Value by Region (2024-2029) & (USD Million)

Table 102. South America Respiratory Syncytial Virus Vaccines Consumption Value by Type (2018-2023) & (USD Million)

Table 103. South America Respiratory Syncytial Virus Vaccines Consumption Value by Type (2024-2029) & (USD Million)

Table 104. South America Respiratory Syncytial Virus Vaccines Consumption Value by Application (2018-2023) & (USD Million)

Table 105. South America Respiratory Syncytial Virus Vaccines Consumption Value by Application (2024-2029) & (USD Million)

Table 106. South America Respiratory Syncytial Virus Vaccines Consumption Value by Country (2018-2023) & (USD Million)

Table 107. South America Respiratory Syncytial Virus Vaccines Consumption Value by Country (2024-2029) & (USD Million)

Table 108. Middle East & Africa Respiratory Syncytial Virus Vaccines Consumption Value by Type (2018-2023) & (USD Million)

Table 109. Middle East & Africa Respiratory Syncytial Virus Vaccines Consumption Value by Type (2024-2029) & (USD Million)

Table 110. Middle East & Africa Respiratory Syncytial Virus Vaccines Consumption Value by Application (2018-2023) & (USD Million)

Table 111. Middle East & Africa Respiratory Syncytial Virus Vaccines Consumption Value by Application (2024-2029) & (USD Million)

Table 112. Middle East & Africa Respiratory Syncytial Virus Vaccines Consumption Value by Country (2018-2023) & (USD Million)

Table 113. Middle East & Africa Respiratory Syncytial Virus Vaccines Consumption Value by Country (2024-2029) & (USD Million)

Table 114. Respiratory Syncytial Virus Vaccines Raw Material

Table 115. Key Suppliers of Respiratory Syncytial Virus Vaccines Raw Materials

List of Figures

Figure 1. Respiratory Syncytial Virus Vaccines Picture

Figure 2. Global Respiratory Syncytial Virus Vaccines Consumption Value by Type, (USD Million), 2018 & 2022 & 2029

Figure 3. Global Respiratory Syncytial Virus Vaccines Consumption Value Market Share by Type in 2022

Figure 4. Palivizumab

Figure 5. RSVpreF PF06928316

Figure 6. RSVPreF3 OA (GSK3844766A)

Figure 7. mRNA-1345

Figure 8. Janssen RSV Vaccine

Figure 9. ResVax

Figure 10. Nirsevimab (MEDI8897)

Figure 11. MVA-BN RSV

Figure 12. Global Respiratory Syncytial Virus Vaccines Consumption Value by Type, (USD Million), 2018 & 2022 & 2029

Figure 13. Respiratory Syncytial Virus Vaccines Consumption Value Market Share by Application in 2022

Figure 14. Hospital Picture

Figure 15. Clinic Picture

Figure 16. Research Institute Picture

Figure 17. Global Respiratory Syncytial Virus Vaccines Consumption Value, (USD Million): 2018 & 2022 & 2029

Figure 18. Global Respiratory Syncytial Virus Vaccines Consumption Value and Forecast (2018-2029) & (USD Million)

Figure 19. Global Market Respiratory Syncytial Virus Vaccines Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)

Figure 20. Global Respiratory Syncytial Virus Vaccines Consumption Value Market Share by Region (2018-2029)

Figure 21. Global Respiratory Syncytial Virus Vaccines Consumption Value Market Share by Region in 2022

Figure 22. North America Respiratory Syncytial Virus Vaccines Consumption Value (2018-2029) & (USD Million)

Figure 23. Europe Respiratory Syncytial Virus Vaccines Consumption Value (2018-2029) & (USD Million)

Figure 24. Asia-Pacific Respiratory Syncytial Virus Vaccines Consumption Value (2018-2029) & (USD Million)

Figure 25. South America Respiratory Syncytial Virus Vaccines Consumption Value (2018-2029) & (USD Million)

Figure 26. Middle East and Africa Respiratory Syncytial Virus Vaccines Consumption Value (2018-2029) & (USD Million)

Figure 27. Global Respiratory Syncytial Virus Vaccines Revenue Share by Players in 2022

Figure 28. Respiratory Syncytial Virus Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022

Figure 29. Global Top 3 Players Respiratory Syncytial Virus Vaccines Market Share in 2022

Figure 30. Global Top 6 Players Respiratory Syncytial Virus Vaccines Market Share in 2022

Figure 31. Global Respiratory Syncytial Virus Vaccines Consumption Value Share by Type (2018-2023)

Figure 32. Global Respiratory Syncytial Virus Vaccines Market Share Forecast by Type (2024-2029)

Figure 33. Global Respiratory Syncytial Virus Vaccines Consumption Value Share by Application (2018-2023)

Figure 34. Global Respiratory Syncytial Virus Vaccines Market Share Forecast by Application (2024-2029)

Figure 35. North America Respiratory Syncytial Virus Vaccines Consumption Value Market Share by Type (2018-2029)

Figure 36. North America Respiratory Syncytial Virus Vaccines Consumption Value Market Share by Application (2018-2029)

Figure 37. North America Respiratory Syncytial Virus Vaccines Consumption Value Market Share by Country (2018-2029)

Figure 38. United States Respiratory Syncytial Virus Vaccines Consumption Value (2018-2029) & (USD Million)

Figure 39. Canada Respiratory Syncytial Virus Vaccines Consumption Value (2018-2029) & (USD Million)

Figure 40. Mexico Respiratory Syncytial Virus Vaccines Consumption Value (2018-2029) & (USD Million)

Figure 41. Europe Respiratory Syncytial Virus Vaccines Consumption Value Market Share by Type (2018-2029)

Figure 42. Europe Respiratory Syncytial Virus Vaccines Consumption Value Market Share by Application (2018-2029)

Figure 43. Europe Respiratory Syncytial Virus Vaccines Consumption Value Market Share by Country (2018-2029)

Figure 44. Germany Respiratory Syncytial Virus Vaccines Consumption Value (2018-2029) & (USD Million)

Figure 45. France Respiratory Syncytial Virus Vaccines Consumption Value (2018-2029) & (USD Million)

Figure 46. United Kingdom Respiratory Syncytial Virus Vaccines Consumption Value (2018-2029) & (USD Million)

Figure 47. Russia Respiratory Syncytial Virus Vaccines Consumption Value (2018-2029) & (USD Million)

Figure 48. Italy Respiratory Syncytial Virus Vaccines Consumption Value (2018-2029) & (USD Million)

Figure 49. Asia-Pacific Respiratory Syncytial Virus Vaccines Consumption Value Market Share by Type (2018-2029)

Figure 50. Asia-Pacific Respiratory Syncytial Virus Vaccines Consumption Value Market Share by Application (2018-2029)

Figure 51. Asia-Pacific Respiratory Syncytial Virus Vaccines Consumption Value Market Share by Region (2018-2029)

Figure 52. China Respiratory Syncytial Virus Vaccines Consumption Value (2018-2029) & (USD Million)

Figure 53. Japan Respiratory Syncytial Virus Vaccines Consumption Value (2018-2029) & (USD Million)

Figure 54. South Korea Respiratory Syncytial Virus Vaccines Consumption Value (2018-2029) & (USD Million)

Figure 55. India Respiratory Syncytial Virus Vaccines Consumption Value (2018-2029) & (USD Million)

Figure 56. Southeast Asia Respiratory Syncytial Virus Vaccines Consumption Value (2018-2029) & (USD Million)

Figure 57. Australia Respiratory Syncytial Virus Vaccines Consumption Value (2018-2029) & (USD Million)

Figure 58. South America Respiratory Syncytial Virus Vaccines Consumption Value Market Share by Type (2018-2029)

Figure 59. South America Respiratory Syncytial Virus Vaccines Consumption Value Market Share by Application (2018-2029)

Figure 60. South America Respiratory Syncytial Virus Vaccines Consumption Value Market Share by Country (2018-2029)

Figure 61. Brazil Respiratory Syncytial Virus Vaccines Consumption Value (2018-2029) & (USD Million)

Figure 62. Argentina Respiratory Syncytial Virus Vaccines Consumption Value (2018-2029) & (USD Million)

Figure 63. Middle East and Africa Respiratory Syncytial Virus Vaccines Consumption Value Market Share by Type (2018-2029)

Figure 64. Middle East and Africa Respiratory Syncytial Virus Vaccines Consumption Value Market Share by Application (2018-2029)

Figure 65. Middle East and Africa Respiratory Syncytial Virus Vaccines Consumption Value Market Share by Country (2018-2029)

Figure 66. Turkey Respiratory Syncytial Virus Vaccines Consumption Value (2018-2029) & (USD Million)

Figure 67. Saudi Arabia Respiratory Syncytial Virus Vaccines Consumption Value (2018-2029) & (USD Million)

Figure 68. UAE Respiratory Syncytial Virus Vaccines Consumption Value (2018-2029) & (USD Million)

Figure 69. Respiratory Syncytial Virus Vaccines Market Drivers

Figure 70. Respiratory Syncytial Virus Vaccines Market Restraints

Figure 71. Respiratory Syncytial Virus Vaccines Market Trends

Figure 72. Porters Five Forces Analysis

Figure 73. Manufacturing Cost Structure Analysis of Respiratory Syncytial Virus Vaccines in 2022

Figure 74. Manufacturing Process Analysis of Respiratory Syncytial Virus Vaccines

Figure 75. Respiratory Syncytial Virus Vaccines Industrial Chain

Figure 76. Methodology

Figure 77. Research Process and Data Source